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Methods: Recipient C57Bt/6 mice received 13Gy 
of totat body irradiation and were rescued with BM 
obtained from femurs of donor C57Bt/6 mice. Res- 
ident AMs and recruited tung PMNs were harvested 
3 to 5 weeks post-BMT and their eicosanoid profite 
were examined. We measured the Fc and non-Fc 
mediated phagocytosis and kitting of AMs and PMNs 
post-BMT. Indomethacin, a PG inhibitor, was used 
to brock PGE2 production in vitro and in vivo. 
Results: BMT AMs produce 125-times more PGE2 
than controt AMs and BMT PMNs produce 27-ford 
more PGE2 than controt PMNs. We have shown that 
the increased susceptibitity of BMT mice corretates 
with defective AM phagocytosis and kitting of Gram- 
negative bacteria. Interestingty, PMNs from BMT 
mice do not disptay defective phagocytosis, but 
do show a defect in their abitity to kitt ingested 
Gram-negative bacteria. The pharmacotogic btock- 
ade of prostagtandin production by indomethacin in 
vitro restores AM phagocytosis and kitting and PMN 
kitting. In addition, treatment with indomethacin 
restores host defense to P. aeruginosa in vivo. 
Conclusions: We show that eicosanoid dysregu- 
ration post-BMT inhibits the effectiveness of the 
innate immune response. Inhibiting PGs in vitro and 
in vivo restores impaired putmonary host defense 
post-BMT. 
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Background: Bone marrow transptantation (BMT) 
is used in the treatment of various matignan- 
cies. The success of BMT is timited by muttipte 
comptications inctuding putmonary infections both 
pre-engraftment and after engraftment has oc- 
curred. We previousty demonstrated that mice af- 
ter BMT have an increased susceptibitity to Gram- 
negative bacteriat pneumonia after engraftment. 
This appears to be due to impaired tung innate 
immunity with defective phagocytosis in atveo- 
tar macrophages, and defective kitting in tung 
neutrophits. Response to vaccination is dimin- 
ished in patients post-BMT indicating that there 
are adaptive immune defects as wett. To fur- 
ther etucidate the adaptive immune defects in 
rungs post-BMT, we anatyzed a tung infection with 
muMne gammaherpesvirus-68 (MHV-68). MHV-68 is 
a ds-DNA virus that is most simitar to Epstein 
Barr virus (EBV) and Kaposi sarcoma-associated 
herpesvirus (KSHV) in humans. 
Objective: Our hypothesis is that dysregutation in 
the adaptive immune response in the rungs post- 
BMT reads to increased susceptibitity to virat in- 
fection. 
Methods: Syngeneic BMT was performed in recip- 
ient C57Bt/6 mice receiving 13Gy of totat body 
irradiation, rescued with bone marrow obtained 
from the femurs of donor C57Bt/6 mice. Con- 
trot (untransptanted) and BMT mice were infected 
with 5x104 ptaque forming units (PFUs) MHV-68 
intranasatty at 6 weeks post-BMT. PFUs were mea- 
sured from tung homogenates at days 3, 5, 7, 9, 
and 14 post-infection. Cett counts and differentiats 
were performed and tymphocyte subsets were an- 
atyzed with flow cytometry. Cytokine revers were 
measured using ELISA. 
Results: Mice that have undergone BMT have 25- 
times the PFUs at day 7 post-infection versus con- 
trot mice. There is an increase in the percentage 
of neutrophits, and a decrease in tymphocytes in 
BMT mice versus controt mice. There is a decrease 
in the percentage of CD8+ T-cetts, but no change 
in CD4+ T-cetts, B-cetts, or NK cetts. There is no 
difference in TNF atpha revers in BMT versus controt 
mice post infection. White IFN-gamma increased in 
controt mice, no increase was seen in BMT mice 
post infection. 
Conclusion: Mice post-BMT have an increased sus- 
ceptibitity to [ytic tung infection with MHV-68 after 
futt engraftment has occurred. This finding is tikety 
retated to both innate and adaptive immune de- 
fects. 
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Background & Objectives: The cytomegalovirus 
(CMV) gtycoprotein B (gB) is the major envetope 
gtycoprotein, encoded by the UL55 gene. Based on 
sequence variation in the UL55 gene, CMV can be 
ctassified into four gB genotypes. Previous studies 
have suggested there coutd be an association be- 
tween CMV gB genotype and ctinica[ outcome in 
the immunocompromised hosts. The goat of this 
study was to determine the distribution of CMV 
gB genotypes and the effect of gB genotype in 
the devetopment of CMV diseases in hematopoietic 
stem cet[ transptant (HSCT) recipients in Korea. 
